Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maret Bauer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Letters|September 24, 2008
Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signallingMarion T Weigel, Ivo Meinhold-Heerlein, Dirk O Bauerschlag, et al.
Anticancer Research|April 9, 2013
Normal mammary fibroblasts induce reversion of the malignant phenotype in human primary breast cancerAnna-Maria Römer, Inke Lühr, Andreas Klein, et al.
International Journal of Clinical Oncology|November 18, 2015
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancerAntonia Wenners, Felix Hartmann, Arne Jochens, et al.
BMC Cancer|August 10, 2010
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cellsMarion T Weigel, Linda Dahmke, Christian Schem, et al.
Anticancer Research|July 2, 2014
Significance of syndecan-1 expression in ductal carcinoma in situ of the breastKatharina Tiemann, Marion Tina Weigel, Ibrahim Alkatout, et al.
The International Journal of Biological Markers|May 13, 2020
Cytoplasmic levels of high mobility group A2 determine survival prognoses in breast cancer patientsThorsten Heilmann, Florian Vondung, Christoph Borzikowsky, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 12, 2019
Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patientsThorsten Heilmann, Florian Vondung, Christoph Borzikowsky, et al.
Cancer Letters|July 11, 2012
Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signalsInke Lühr, Andreas Friedl, Thorsten Overath, et al.
Oncology|August 30, 2014
Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancerNicolai Maass, Christian Schem, Dirk O Bauerschlag, et al.
Plos One|October 12, 2012
Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancerAntonia Sophie Wenners, Keyur Mehta, Sibylle Loibl, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Letters|September 24, 2008
Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signallingMarion T Weigel, Ivo Meinhold-Heerlein, Dirk O Bauerschlag, et al.
Anticancer Research|April 9, 2013
Normal mammary fibroblasts induce reversion of the malignant phenotype in human primary breast cancerAnna-Maria Römer, Inke Lühr, Andreas Klein, et al.
International Journal of Clinical Oncology|November 18, 2015
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancerAntonia Wenners, Felix Hartmann, Arne Jochens, et al.
BMC Cancer|August 10, 2010
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cellsMarion T Weigel, Linda Dahmke, Christian Schem, et al.
Anticancer Research|July 2, 2014
Significance of syndecan-1 expression in ductal carcinoma in situ of the breastKatharina Tiemann, Marion Tina Weigel, Ibrahim Alkatout, et al.
The International Journal of Biological Markers|May 13, 2020
Cytoplasmic levels of high mobility group A2 determine survival prognoses in breast cancer patientsThorsten Heilmann, Florian Vondung, Christoph Borzikowsky, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 12, 2019
Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patientsThorsten Heilmann, Florian Vondung, Christoph Borzikowsky, et al.
Cancer Letters|July 11, 2012
Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signalsInke Lühr, Andreas Friedl, Thorsten Overath, et al.
Oncology|August 30, 2014
Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancerNicolai Maass, Christian Schem, Dirk O Bauerschlag, et al.
Plos One|October 12, 2012
Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancerAntonia Sophie Wenners, Keyur Mehta, Sibylle Loibl, et al.
Pageof 3